EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Estrogen Receptor Alpha Gene Single Nucleotide Polymorphisms, +2464 C/T and -4576A/C, and Breast Cancer Risk, a Hospital-Based Case-Control Study

Ali Akbar Amirzargar, Maryam Sadr, Samira Esmaeili Reykande, Elham Mohebbi, Mohammad Shirkhoda, Majid Mahmoodi

Basic & Clinical Cancer Research · 2019

DOI: 10.18502/bccr.v11i2.1655 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Basic & Clinical Cancer Research, 2019. Verfasst von Ali Akbar Amirzargar und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Estrogen is a risk factor for the development of breast cancer. The effect of estrogen is primarily mediated by estrogen receptor alpha 1 (ESR1). In this study, we investigated the association between breast cancer risk and the frequency of alleles and genotypes for two ESR1 single nucleotide polymorphisms (SNPs) in breast cancer patients and a healthy control group.

Methods

A total of 98 female patients with pathologically confirmed breast cancer and 93 age-matched healthy female controls who were selected from the visitors of the general hospital were recruited in the study. Two ESR1 candidate polymorphisms; +2464 C/T (rs3020314) and -4576 A/C (rs1514348) were selected. The frequency of alleles and genotypes was determined using Quantitative Real-Time PCR assay. Linkage disequilibrium (LD) was assessed for each pair of markers. Using logistic regression, genotype frequencies were estimated as odds ratios with 95% confidence intervals.

Results

There was no significant difference in the genotype and allele distributions of ESR1 for SNPs +2464 C/T and SNP -4576 A/C between patients and controls. The frequency of the ESR1 +2464 T/T genotype in case and control groups was 31.6% vs 29.0%, (OR TT/TC: 1.13, 95%CI: 0.58, 2.20; P = 0.69). The frequency of the +2464C allele was 33.9% vs 35.2%, (OR C/T: 0.94, 95%CI: 0.60, 1.47; P =0.79). The frequency of the ESR1 -4576C/C genotype in case and control groups was 37.75% vs 33.36%, OR CC/AC: 1.02, 95%CI: 0.51, 1.97; P =0.98). The frequency of the -4576A allele was 36.2% vs 43.6 %, (OR C/A: 0.73, 95%CI: 0.47, 1.13; P =0.14).

Conclusion

The results indicated that ESR1 polymorphism does not show any significant association with breast cancer risk among female Iranian adults.

Zitieren

APA

Amirzargar, A. A., Sadr, M., Reykande, S. E., Mohebbi, E., Shirkhoda, M., & Mahmoodi, M. (2019). Estrogen Receptor Alpha Gene Single Nucleotide Polymorphisms, +2464 C/T and -4576A/C, and Breast Cancer Risk, a Hospital-Based Case-Control Study. Basic & Clinical Cancer Research. https://doi.org/10.18502/bccr.v11i2.1655

Vancouver

Amirzargar AA, Sadr M, Reykande SE, Mohebbi E, Shirkhoda M, Mahmoodi M. Estrogen Receptor Alpha Gene Single Nucleotide Polymorphisms, +2464 C/T and -4576A/C, and Breast Cancer Risk, a Hospital-Based Case-Control Study. Basic & Clinical Cancer Research. 2019. doi:10.18502/bccr.v11i2.1655

BibTeX
@article{Amirzargar2019,
  author = {Amirzargar, Ali Akbar and Sadr, Maryam and Reykande, Samira Esmaeili and Mohebbi, Elham and Shirkhoda, Mohammad and Mahmoodi, Majid},
  title = {Estrogen Receptor Alpha Gene Single Nucleotide Polymorphisms, +2464 C/T and -4576A/C, and Breast Cancer Risk, a Hospital-Based Case-Control Study},
  journal = {Basic & Clinical Cancer Research},
  year = {2019},
  doi = {10.18502/bccr.v11i2.1655}
}
Kostenlos starten →